2 Discovery of Cep-1347/Kt-7515, an Inhibitor of the Jnk/Sapk Pathway for the Treatment of Neurodegenerative DiseasesMichael S. Saporito, Anna C. Maroney, Robert L. Hudkins|Progress in medicinal chemistry|2002Cited by 98
Mixed lineage kinase activity of indolocarbazole analoguesChikara Murakata, Robert L. Hudkins, Michael S. Saporito et al.|Bioorganic & Medicinal Chemistry Letters|2002Cited by 94
Targeting the JNK Pathway for Therapeutic Benefit in CNS DiseaseDonna Bozyczko‐Coyne, Robert L. Hudkins, Michael S. Saporito|Current Drug Targets - CNS & Neurological Disorders|2002Cited by 69
Mixed-Lineage Kinase 1 and Mixed-Lineage Kinase 3 Subtype-Selective Dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: Optimization, Mixed-Lineage Kinase 1 Crystallography, and Oral in Vivo Activity in 1-Methyl-4-phenyltetrahydropyridine ModelsRobert L. Hudkins, John P. Mallamo, Jean Husten et al.|Journal of Medicinal Chemistry|2008Cited by 43